Notification of Change in Beneficial Ownership
2026-03-23SEC Filing SCHEDULE 13G (0001104659-26-033404)
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, reported a change in beneficial ownership of Indivior Pharmaceuticals, Inc. common stock. As of March 17, 2026, their ownership stake was 3.8%, amounting to 4,806,556 shares. This represents a change from previous holdings, with the value of the holding increasing from approximately $83.8 million to $140.8 million. The filing indicates that this change in ownership was not for the purpose of influencing the control of the issuer. A joint filing agreement was established on March 20, 2026, to confirm the shared filing responsibilities among the involved parties.
Related industry:Drug Manufacturers - Specialty & Generic
Source:Original SEC Document β